Priscilla Chan and Mark Zuckerberg Distinguished Prof, Director (BCHI), Chief Data Scientist (UC)
1. Bakar Computational Health Sciences Institute, University of California, San Francisco, California, USA
AlphaSights, Covance, Novartis, Genentech, Merck, and Roche (Consultant/Advisory Board)and has received honoraria and travel reimbursement for invited talks from Johnson and Johnson, Roche, Genentech, Pfizer, Merck, Lilly, Takeda, Varian (Consultant/Advisory Board)And in the recent past, 10x Genomics, Helix, Pathway Genomics, and Verinata (Illumina) (Consultant/Advisory Board)Atul Butte is a co-founder and consultant to Personalis and NuMedii; consultant to Samsung, Mango Tree Corporation (Consultant/Advisory Board)Atul Butte receives royalty payments through Stanford University, for several patents and other disclosures licensed to NuMedii and Personalis (Consultant/Advisory Board)Atul Butte’s research has been funded by NIH, Northrup Grumman (as the prime on an NIH contract), Genentech, Johnson and Johnson (Consultant/Advisory Board)California Governor’s Office of Planning and Research, California Institute for Regenerative Medicine, L’Oreal, and Progenity (Consultant/Advisory Board)FDA, Robert Wood Johnson Foundation, Leon Lowenstein Foundation, Intervalien Foundation, Priscilla Chan and Mark Zuckerberg (Consultant/Advisory Board)Has served on paid advisory panels or boards for Geisinger Health, Regenstrief Institute, Gerson Lehman Group (Consultant/Advisory Board)is a shareholder in Personalis and NuMedii; is a minor shareholder in Apple, Facebook, Alphabet (Google) (Consultant/Advisory Board)Mars, Siemens, Optum, Abbott, Celgene, AstraZeneca, AbbVie, Westat, and many academic institutions (Consultant/Advisory Board)medical or disease specific foundations and associations, and health systems (Consultant/Advisory Board)Microsoft, Amazon, Snap, 10x Genomics, Illumina, Nuna Health, Assay Depot, Vet24seven, Regeneron, Sanofi, Royalty Pharma, AstraZeneca, Moderna, Biogen (Consultant/Advisory Board)Paraxel, and Sutro, and several other non-health related companies and mutual funds (Consultant/Advisory Board)the Barbara and Gerson Bakar Foundation, and in the recent past, the March of Dimes, Juvenile Diabetes Research Foundation (Consultant/Advisory Board)